Kissil J - Search Results

1

A combination of novel NSC small molecule inhibitor along with doxorubicin inhibits proliferation of triple-negative breast cancer through metabolic reprogramming.

Yousefi H, Khosla M, Lauterboeck L, Okpechi SC, Worthylake D, Garai J, Zabaleta J, Guidry J, Zarandi MA, Wyczechowska D, Jayawickramarajah J, Yang Q, Kissil J, Alahari SK. Yousefi H, et al. Among authors: kissil j. Oncogene. 2022 Nov;41(47):5076-5091. doi: 10.1038/s41388-022-02497-2. Epub 2022 Oct 15. Oncogene. 2022. PMID: 36243802

2

The role of Motin family proteins in tumorigenesis-an update.

Amirifar P, Kissil J. Amirifar P, et al. Among authors: kissil j. Oncogene. 2023 Apr;42(16):1265-1271. doi: 10.1038/s41388-023-02677-8. Epub 2023 Mar 27. Oncogene. 2023. PMID: 36973516 Review.

3

Cellular transformation by a FERM domain mutant of the Nf2 tumor suppressor gene.

Johnson KC, Kissil JL, Fry JL, Jacks T. Johnson KC, et al. Oncogene. 2002 Sep 5;21(39):5990-7. doi: 10.1038/sj.onc.1205693. Oncogene. 2002. PMID: 12203111

4

The Rac1 splice form Rac1b promotes K-ras-induced lung tumorigenesis.

Zhou C, Licciulli S, Avila JL, Cho M, Troutman S, Jiang P, Kossenkov AV, Showe LC, Liu Q, Vachani A, Albelda SM, Kissil JL. Zhou C, et al. Among authors: kissil jl. Oncogene. 2013 Feb 14;32(7):903-9. doi: 10.1038/onc.2012.99. Epub 2012 Mar 19. Oncogene. 2013. PMID: 22430205 Free PMC article.

5

A novel three-dimensional high-throughput screening approach identifies inducers of a mutant KRAS selective lethal phenotype.

Kota S, Hou S, Guerrant W, Madoux F, Troutman S, Fernandez-Vega V, Alekseeva N, Madala N, Scampavia L, Kissil J, Spicer TP. Kota S, et al. Among authors: kissil j. Oncogene. 2018 Aug;37(32):4372-4384. doi: 10.1038/s41388-018-0257-5. Epub 2018 May 10. Oncogene. 2018. PMID: 29743592 Free PMC article.

6

The use of non-traditional models in the study of cancer resistance-the case of the naked mole rat.

Shepard A, Kissil JL. Shepard A, et al. Among authors: kissil jl. Oncogene. 2020 Jul;39(28):5083-5097. doi: 10.1038/s41388-020-1355-8. Epub 2020 Jun 13. Oncogene. 2020. PMID: 32535616 Review.

7

DAP-kinase loss of expression in various carcinoma and B-cell lymphoma cell lines: possible implications for role as tumor suppressor gene.

Kissil JL, Feinstein E, Cohen O, Jones PA, Tsai YC, Knowles MA, Eydmann ME, Kimchi A. Kissil JL, et al. Oncogene. 1997 Jul 24;15(4):403-7. doi: 10.1038/sj.onc.1201172. Oncogene. 1997. PMID: 9242376

8

The NF2 tumor suppressor merlin interacts with Ras and RasGAP, which may modulate Ras signaling.

Cui Y, Groth S, Troutman S, Carlstedt A, Sperka T, Riecken LB, Kissil JL, Jin H, Morrison H. Cui Y, et al. Oncogene. 2019 Sep;38(36):6370-6381. doi: 10.1038/s41388-019-0883-6. Epub 2019 Jul 16. Oncogene. 2019. PMID: 31312020 Free PMC article.

9

FRAX597, a small molecule inhibitor of the p21-activated kinases, inhibits tumorigenesis of neurofibromatosis type 2 (NF2)-associated Schwannomas.

Licciulli S, Maksimoska J, Zhou C, Troutman S, Kota S, Liu Q, Duron S, Campbell D, Chernoff J, Field J, Marmorstein R, Kissil JL. Licciulli S, et al. Among authors: kissil jl. J Biol Chem. 2013 Oct 4;288(40):29105-14. doi: 10.1074/jbc.M113.510933. Epub 2013 Aug 19. J Biol Chem. 2013. PMID: 23960073 Free PMC article.

10

Crizotinib inhibits NF2-associated schwannoma through inhibition of focal adhesion kinase 1.

Troutman S, Moleirinho S, Kota S, Nettles K, Fallahi M, Johnson GL, Kissil JL. Troutman S, et al. Oncotarget. 2016 Aug 23;7(34):54515-54525. doi: 10.18632/oncotarget.10248. Oncotarget. 2016. PMID: 27363027 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

64 results

Search Page